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Natural killer (NK) cells play an important role in the containment of HIV replication
during primary infection, though their functions are impaired during chronic HIV infection.
Infants experience more rapid HIV disease progression than adults, but contributions of
infant NK cells to containing HIV infection are unknown. The aim of this study was to
determine the impact of HIV infection on infant NK cell phenotype by evaluating samples
and data from a cohort study of women and their infants, conducted in Nairobi, Kenya
between 1999 and 2003. The percentage and phenotype of NK cells was evaluated
longitudinally by multi-parameter flow cytometry over the first year of life in HIV-infected
(HIV+, = 16), HIV-exposed uninfected (HIV-EU, n = 6), and healthy unexposed controls
(HIV–, n = 4). At birth, NK subset distributions based on expression of CD56 and CD16
did not differ between HIV+, HIV-EU, or HIV– infants. However, HIV infection was
associated with a subsequent decline in NK cells as a percentage of total lymphocytes
(p < 0.001), and an expanding proportion of CD56-CD16+ NK cells (p < 0.001). Activated
CD38brightCD69+ NK cells were more frequent in the HIV+ infants, followed by HIV-EU
and HIV- infants, in both CD56dim (p = 0.005) and CD56bright compartments (p = 0.03). HIV
infection and exposure was also associated with a significant decline in the percentage
of perforin-expressing NK cells in the CD56dim compartment over the first year of life,
with HIV+ infants losing approximately 2.5% (p < 0.001) and HIV-EU infants losing 3.0%
(p = 0.01) of perforin+ cells per month. Thus, infant HIV infection is associated with
alterations in NK cell subsets, activation, and cytolytic potential that could contribute to
their poor control over HIV infection. Furthermore, exposure to HIV infection in infants
who escaped infection is also associated with alterations in NK cells that may contribute
to the reduced ability to fight infections that is observed in HIV-EU infants.
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INTRODUCTION
Natural killer (NK) cells are innate lymphocytes that can respond
quickly, without prior sensitization, to eliminate virus-infected
cells, making them critical in the early response to viral infection
(Cerwenka and Lanier, 2001; Lanier, 2008; Biron, 2010; Vivier
et al., 2011). Recent evidence from studies conducted in adults
have highlighted a significant role for NK cells in the control and
prevention of HIV-1 infection (Cerwenka and Lanier, 2001; Fauci
et al., 2005; Lanier, 2008; Alter and Altfeld, 2009; Biron, 2010;
Tomescu et al., 2011; Vivier et al., 2011). Although innate immu-
nity plays a key role in neonatal defenses as the adaptive immune
response develops, very few studies have examined role of NK
cells in the defense against infant HIV acquisition, or the contain-
ment of HIV after infection (Bernstein et al., 2004; Azzoni et al.,
2005; Ballan et al., 2007).
Infant HIV infection is characterized by very poor contain-
ment of HIV replication; both peak and set point viral load are
often >1 log higher than in adults, and are higher among infants
infected peripartum compared to those infected later via breast
milk (Richardson et al., 2003). These high infant viral loads are
associated with a very high risk of mortality in the absence of
antiretroviral therapy (ART) (Blanche et al., 1990; De Rossi et al.,
1996; Dickover et al., 1998; Luzuriaga et al., 1999; Obimbo et al.,
2004). In the setting of ART, infants attain viral suppression more
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slowly than adults and many fail to achieve suppression after
>24 months of therapy (Penazzato et al., 2012). In adults, HIV-
specific T cell responses contribute to the rapid decline in HIV
viral load during the first weeks of primary infection (Walker
et al., 1991; Koup et al., 1994; Bollinger et al., 1996; Hess et al.,
2004); in infants, this pattern is often absent, and is attributed
to a combination of lower HIV-specific T cell numbers, altered
T cell phenotype, fewer polyfunctional cells, and early emergence
of CTL escape mutations (Goulder et al., 2001; Hansasuta and
Rowland-Jones, 2001).
In this setting of sub-optimal T cell responses, NK cells could
potentially play a very important role in infant primary HIV
infection. While NK cells appear to be critical for the early
containment of HIV infection in adults, their phenotype and
functions were found to be dramatically altered following HIV
acquisition. Acute HIV infection is characterized by an early
expansion of NK cells, particularly of the CD3-CD56dim subset
(Hu et al., 1995; Alter et al., 2007). Although there are reports
of increased NK cell activity during viremic HIV infection (Alter
et al., 2004; Eller et al., 2009), during the chronic phase of HIV
infection, NK cell numbers are low in the absence of ART (Azzoni
et al., 2002; Alter et al., 2005; Mantegani et al., 2010), and most
have diminished ability to perform cytolysis and secrete cytokines
(Cai et al., 1990; Brenner et al., 1993; Ullum et al., 1995, 1999;
Azzoni et al., 2002; De Maria et al., 2003; Mavilio et al., 2003,
2006; Fogli et al., 2004; Barker et al., 2007; Brunetta et al., 2009;
Mantegani et al., 2010). Chronic HIV infection also leads to alter-
ations in the NK cell subset distribution, with a decline in the
proportion of CD56+ NK cells and a dramatic expansion of
CD56-CD16+ NK cells (reviewed in Alter and Altfeld, 2009).
These alterations in phenotype and percentage may be partially
reversed by administration of ART, implicating active viral repli-
cation in inducing these changes (Mavilio et al., 2003, 2006; Alter
and Altfeld, 2009). The CD56-CD16+ NK cells lack most effec-
tor functions and appear to be anergic (Alter and Altfeld, 2009).
Chronic HIV infection is also associated with phenotypic changes
in NK cells, including increased expression of activation mark-
ers and reduced expression of natural cytotoxicity receptors (De
Maria et al., 2003; Fogli et al., 2004; Mantegani et al., 2010).
To our knowledge, only two studies have directly examined
NK cells in children who were HIV-infected during infancy. In
one study, HIV-infected children (median age 11.1 years) had a
sustained depletion in NK cells that only partially recovered with
ART (Azzoni et al., 2005). In the second study, there were no sig-
nificant differences in the NK cell subset distribution between
HIV-infected children receiving ART (median age 8.2 years)
and HIV-exposed uninfected children (median age 5.5) children
(Ballan et al., 2007). However, the NK cells from the HIV-infected
children had some phenotypic differences and decreased cytolytic
activity in comparison to the NK cells from the HIV-exposed
uninfected children (Ballan et al., 2007). These data indicate that
chronic HIV infection in children can impair NK cell function,
but these studies were subject to survivor bias, and they were not
able to examine early events in infancy, when NK cells might be
particularly important to control HIV infection.
Since the early response to HIV infection is critical in deter-
mining the subsequent disease course (Mellors et al., 1996; Lifson
et al., 1997; Gandhi and Walker, 2002), it is important to under-
stand the dynamics of early infection in infants. Our prior studies
in this cohort demonstrated that HIV-infected neonates could
generate CD8+ T cell responses early in life, but that these were
not associated with improved clinical outcomes (Lohman et al.,
2005). Furthermore, infant T cells were persistently activated and
vulnerable to apoptosis (Slyker et al., 2011), which could explain
in part their reduced effectiveness in containing viremia. We
hypothesized that age and HIV exposure would also affect NK
cell phenotype during the first year of life. In the current study, we
present a longitudinal analysis of the percentage and phenotype of
NK cells over the first year of life in HIV-infected, HIV-exposed
uninfected, and healthy HIV-unexposed infants, and examine the
relationship between NK cell phenotype and HIV viral load.
MATERIALS ANDMETHODS
PARTICIPANTS AND SPECIMEN COLLECTION
Study protocols were performed in accordance with all relevant
institutional and national guidelines and were approved by the
Ethics Review Committees of Kenyatta National Hospital and
University of Washington. Frozen PBMC specimens were uti-
lized from an historic cohort study conducted in Nairobi, Kenya
from 1999 to 2003 as previously described (Obimbo et al., 2004;
Lohman et al., 2005; John-Stewart et al., 2009; Slyker et al., 2011).
Between 1999 and 2003, HIV-1 infected women were recruited
during pregnancy and provided with short-course zidovudine for
prevention of HIV-1 transmission (Shaffer et al., 1999). Infants
who acquired HIV infection were followed for 2 years follow-
ing delivery; infants that were HIV-exposed but uninfected were
followed for 12 months. Serial infant blood specimens were
collected at delivery, and 1, 3, 6, 9, 12, 15, 18, 21, and 24
months of age. A set of HIV-uninfected women and their children
(HIV-unexposed) were additionally enrolled as controls; these
women were recruited from the same antenatal clinics as the HIV-
infected women. Healthy, HIV-unexposed infants were followed
for six months, with blood collection at delivery and 6 months of
age only.
Infant peripheral blood and cord blood was collected into
EDTA tubes and separated into plasma and PBMC using density-
gradient centrifugation over Ficoll (GE Healthcare, Chicago, IL,
USA). Plasma was frozen at −70◦C; PBMC were cryopreserved
in fetal calf serum (FCS) supplemented with 10%DMSO freezing
media and stored in liquid nitrogen. Between 2 and 10 million
PBMC were frozen in each vial.
IMMUNOPHENOTYPING NK CELLS
Flow cytometry experiments were conducted on frozen speci-
mens between 2005 and 2006. A sample of infants was selected
for immunology assays based upon the availability of cryopre-
served PBMC specimens. The median viability of thawed PBMCs
during this time was 72.4% (interquartile range 60.0–80.5%). As
previously described, cells were stained with panels of antibodies
to identify activated and apoptosis-vulnerable T cells (Slyker
et al., 2011, 2012). Cells were thawed in FCS, washed twice
with PBS plus 0.5% BSA and 0.5mM EDTA (PBE), and stained
with CD3-Pacific Blue (UCHT1, Dakocytomation, Angel Drove,
UK), CD4-APC-Cy7 (RPA-T4, BD Pharmingen, Oxford, UK),
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CD8-PE-Cy7 (RPA-T8, Pharmingen), CD56-PE-Cy5 (N901
(NKH-1), Beckman Coulter, High Wycombe, UK), CD16-APC-
Cy7 (3G8, Pharmingen), CD69-FITC (FN50, Dakocytomation),
CD38-PE (AT13/5, Serotec, Oxford, UK), HLA-DR-APC
(TU36, Pharmingen), CD57-FITC (TB01, Serotec), CD71-APC
(M-A712, Pharmingen), CD95-APC (DX2, Pharmingen), Bcl-2-
FITC (124, Dakocytomation), Perforin-PE (27-35, Pharmingen),
CD27-APC (0323, eBioscience, San Diego, CA, USA), CD28-
FITC (CD28.1, Dakocytomation), CCR7-PE (FAB197, R&D
Systems, Minneapolis, MN, USA) and CD45RA-APC (HI-100,
Pharmingen). Cells were stained for 20min in the dark, and
washed twice with PBE and resuspended in CellFix solution
(Pharmingen). In all assays, fixed and stained cells were stored
overnight at 4◦C and analyzed the next morning in Nairobi,
Kenya.
Cells were acquired on a Cyan ADP or LX instrument using
Summit software (Dako Cytomation, Angel Drove, UK) and data
were analyzed with FlowJo software v8.8.7 (Treestar, Inc., Olten,
Switzerland). Isotype controls were used to set gates for pheno-
typic markers. In order to minimize intra-patient variability, all
time-points for a single infant were thawed, stained, and analyzed
at the same time. Gates were set using the earliest infant sample
available, then applied to all subsequent time-points. This enabled
us to track migration of cells between quadrants and gates as a
function of time.
HIV-1 DIAGNOSIS AND QUANTIFICATION
HIV-1 RNA viral loads were measured from cryopreserved
plasma using the Gen-Probe assay (Emery et al., 2000) and dried
blood spots were used for DNA PCR of the HIV-gag gene as
previously described (Panteleeff et al., 1999). Infant HIV-1 infec-
tion was defined by two consecutive positive results as measured
by either HIV-1 RNA or DNA. Infants with HIV-1 detection in
the first 48 h were considered in utero transmissions; those with
infection between 48 h and 1 month were considered peripartum
transmissions. No infants with HIV-1 acquisition after 1 month
were included in the current study.
STATISTICAL ANALYSES
Stata SE v11 (Stata Corp. College Station, TX, USA) was used
for all statistical analyses. All tests were two-tailed. NK sub-
set distributions were compared between infant groups at birth;
Kruskal–Wallis tests were used to assess for overall differences,
then pairwise Mann–Whitney U-tests were used to assess differ-
ences between groups.
Linear mixed models (LMM) were used to assess whether
the % of NK cells (gated on lymphocytes), or NK cell subsets
(%CD56bright, %CD56+CD16+, and %CD56-CD16+, gated on
total NK cells), changed during the first year of life. Models were
run separately for each HIV infection group.
LMM was also used to compare the phenotype of CD56bright
to the phenotype of CD56dim cells within individual infants. The
[CD56subset] term indicated whether the cells were gated on
CD56bright = 1 or CD56dim = 0. For each phenotype, an LMM
was fitted that included [CD56subset] and [time]. LMM models
were run separately for HIV-infected, HIV-exposed uninfected,
and HIV-unexposed infants. Point estimates (mean differences)
for each phenotype were similar for infants in each group, so the
final data presented show all infants as a single group.
For all phenotypic analyses comparing HIV infection groups
over time, data were analyzed separately for CD56bright and
CD56dim subsets. To determine the effect of HIV status on
NK phenotype, we created a variable scaled by increasing HIV
exposure [HIV status]: HIV-unexposed = 0, HIV-exposed unin-
fected = 1, HIV-infected = 2. LMM were used to assess whether
the percentage of cells of each phenotype (activated, apoptosis-
vulnerable, etc.) changed over time. For each phenotype, a model
was fit that included: a main term [HIVstatus] for HIV exposure,
age in months [time], and an interaction term for [HIVstatus] ×
[time]. When the p-value for the interaction term was >0.05,
the slopes for HIV-infected, HIV-exposed uninfected, and HIV-
unexposed infants were considered equivalent, the interaction
term was removed from the model, and we report the overall
combined slope. For each phenotype, we also present the beta-
coefficient for the HIV status term, which estimates the mean dif-
ference in percentage of cells incrementally between the categories
of HIV-unexposed, HIV-exposed uninfected, and HIV-infected
infants. We additionally report individual slopes and for HIV-
infected, HIV-exposed uninfected, and HIV-unexposed infants.
We also used LMM to examine the relationship between percent-
ages of activated and apoptosis-vulnerable cells in the CD56bright
subset, with [%CD38brightHLA-DR+] and [time] as main terms,
including all of the infants.
In HIV-infected infants, LMM models were used to assess
whether the % of cells of each phenotype were associated with
log10 HIV RNA viral load at the concurrent time-point. Models
were also adjusted for time (age in months). For each phenotype,
an LMM was fitted that included [log10 HIV RNA viral load]
and [time].
All LMMmodels described above included random intercepts
and slopes and unstructured covariance matrices. All tests were
two-tailed, using alpha = 0.05.
RESULTS
STUDY PARTICIPANTS AND FOLLOW-UP
Samples from 26 infants who were enrolled in a historical cohort
study of mother to child transmission of HIV-1 were evaluated
to determine the effects of HIV-1 infection and exposure on NK
cell percentage and phenotype (Table 1). Sixteen infants were
HIV-infected, and of those, 6 were infected in utero and 10 were
infected in the first month of life (peripartum). The HIV-infected
infants had a mean peak viral load of 7.1 log10 copies/mL and
56% died before two years of age. HIV-exposed uninfected infants
(n = 6), and healthy control infants (HIV-unexposed, n = 4) all
survived follow-up. Samples from a median of 5 time points from
HIV-infected and HIV-exposed uninfected infants were evalu-
ated; samples from HIV-unexposed infants were tested at two
time points, birth and at 6 months of age.
DISTRIBUTION OF NK CELL SUBSETS IN HIV-INFECTED, HIV-EXPOSED
UNINFECTED, AND HEALTHY INFANTS AT BIRTH
The major NK cell subsets were defined by excluding granulated
cells, dead cells, and debris by size and granularity (Figure 1A).
Next, CD3 expression was used to exclude T cells, and NK
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cells were identified on the basis of expression of CD56 and/or
CD16. Three distinct subsets comprised the total NK cell pool:
CD56bright cells, CD56+CD16+ cells, and CD56-CD16+ cells
(Figure 1A). In staining panels in which CD16 was not available,
Table 1 | Characteristics of study subjects.
Characteristic HIV+a HIV-EUb HIV-c
Number of infants 16 6 4
Infected in uterod 6 – –
Infected peripartume 10 – –
Median follow-up time in
months (IQR)
12 (7.5–21) 12 (12–12) 6 (3–6)
Median number of study
visits tested
5 (3–5.5) 5 (3–6) 2 (1.5–2)
Mean (±SD) peak plasma
HIV-1 viral load
(log10 copies/mL)
7.1 (±0.64) NA NA
Deaths 9 (56%) 0 0
aHIV+: HIV-infected.
bHIV-EU: HIV-exposed uninfected.
cHIV-: Healthy HIV-unexposed control infants.
d In utero infection was determined on the basis of HIV DNA or RNA detected
<48 h of birth.
ePeripartum HIV infection was defined as HIV DNA or RNA negative at <48 h
and positive at 1 month.
CD56- NK cells could not be identified, but NK cells were
identified as small CD3-lymphocytes that were characterized as
CD56dim and CD56bright NK cells (Figure 1B).
At birth, NK cells comprised approximately 13% of lympho-
cytes (Table 2), consistent with previous studies (Luevano et al.,
2012). The majority of infant NK cells were CD56dimCD16+
(median of 75%), and the minority were CD56bright (median
of 6.0%). CD56-CD16+ cells, previously observed both in cord
blood and during chronic HIV-1 infection (Alter et al., 2005;
Verneris and Miller, 2009; Luevano et al., 2012), were detected
in all groups at birth, and comprised 18% of total NK cells. We
detected no significant differences in subset distributions between
infants categorized by HIV status or exposure at birth (p > 0.05
for each comparison).
CHANGES IN THE DISTRIBUTION OF NK CELL SUBSETS OVER TIME
Figure 2 shows changes in the distribution of NK cell subsets
over time in HIV-infected, HIV-exposed uninfected, and HIV-
unexposed infants. In HIV-infected infants, the total NK cell
percentage decreased over time at a rate of 0.90% per month
(p < 0.001). The total NK cell percentage did not change sig-
nificantly over time in HIV-exposed uninfected (−0.11% per
month, p = 0.5) and HIV-unexposed infants (0.16% per month,
p = 0.8).
As a percentage of total NK cells, CD56bright cells remained
stable over time in all groups of infants. In HIV-infected infants,
CD56+CD16+ cells declined at a rate of –1.3% per month (p <
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FIGURE 1 | Gating strategy to identify NK subsets. Representative flow
cytometry plots from the cord blood of one representative subject within the
cohort (subject B1-081) to demonstrate gating strategy. (A) In panels that
included CD16 as a maker, NK cell subsets were identified by sequentially
gating on lymphocytes, then CD3-cells, then cells expressing CD16 and/or
CD56. NK cell subsets were identified as CD56bright (upper right gate),
CD56+CD16+, and CD56-CD16+. (B) In panels without CD16 staining, NK
cells were identified as CD3-lymphocytes that were either bright (CD56bright)
or dim (CD56dim) for CD56 staining; the CD56-population could not be
distinguished.
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Table 2 | Distribution of NK cell subsets in HIV-unexposed, HIV-exposed uninfected, and HIV-infected infants at birth.
All infants (n = 22) HIV+a (n = 5) HIV-EU (n = 5) HIV- (n = 4) Kruskal–Wallis P-valueb
Total NKc 13 (7.3–19) 16 (7.3–35) 11 (7.3–13) 17 (10–21) 0.6
CD56bright 6.0 (4.6–8.3) 8.3 (5.9–9.5) 6.1 (5.5–6.3) 4.9 (3.3–10) 0.8
CD56+CD16+ 75 (68–84) 75 (70–77) 79 (75–80) 85 (76–86) 0.4
CD56-CD16+ 18 (14–21) 19 (14–21) 18 (14–19) 12 (8.8–15) 0.2
aHIV+, HIV-infected; HIV-EU, HIV-exposed uninfected; HIV-, healthy HIV-unexposed control infants.
bAll pair-wise tests between infants grouped by HIV-1 infection, p > 0.05.
cTotal NK = Percentage of CD3-CD56+ and CD3-CD16+ cells in lymphocyte gate. All other subsets as % of total NK population. Due to rounding percentages will
not add exactly to 100%.
0.001) in parallel with an increase in CD56-CD16+ cells at a rate
of +1.1% per month (p < 0.001), consistent with the current
hypothesis that CD56+CD16+ cells lose CD56 expression in
response to persistent stimulation during chronic viral infection
(Alter et al., 2005; Björkström et al., 2010). Although we had
limited power to detect time trends in HIV-exposed uninfected
and HIV-unexposed infants, we observed similar trends in the
changes in subset distribution over time.
PHENOTYPIC COMPOSITION OF THE NK CELL SUBSETS
The activation and differentiation status of NK cells was assessed
by the expression of several surface and intracellular mark-
ers. Regardless of infection status, NK cells were uniformly
CD38+ throughout most of infancy, expressed CD45RA and
lacked expression of CD28 and CCR7 (data not shown). NK
cells were defined as early activated (CD38+CD69+), activated
(CD38brightHLA-DR+), vulnerable to apoptosis (CD95+Bcl-
2low), proliferating (CD71+CD57–), terminally differentiated
(CD71-CD57+) or potentially cytolytic (perforin+). The phe-
notype of cells differed remarkably between CD56bright and
CD56dim NK subsets in all infants regardless of their infec-
tion status. Table 3 shows the mean difference in % of cells of
each phenotype between the CD56bright and CD56dim NK sub-
sets. For example, at any given time-point, there were 4.1%
fewer CD38brightCD69+ cells in the CD56bright compared to
the CD56dim subset. Cells of the CD56bright subset contained
the majority of cells that were proliferating (CD71+CD57−)
and were vulnerable to apoptosis (CD95+Bcl-2dim), while the
CD56dim subset contained the majority of cells that expressed the
early activation marker CD69 (CD38brightCD69+), were termi-
nally differentiated (CD71−CD57+), and had cytolytic potential
(perforin+). When stratified by HIV status, we saw a very simi-
lar pattern of differences between NK subsets; despite the reduced
statistical power, point estimates were very similar between HIV-
infected and HIV-exposed uninfected (data not shown).
NK CELL ACTIVATION DURING ACUTE HIV INFECTION
NK cells expressing the activation markers CD69 and HLA-DR
were detected among all NK subsets (Figures 3A,B and 4A,B). In
the CD56bright subset, the mean percentage of CD38brightCD69+
cells in HIV-infected infants was 6.9% higher than HIV-exposed
uninfected and 13.8% higher than HIV-unexposed infants
(p = 0.03, Figure 3C). A similar pattern was observed in the
CD56dim subset, the mean percentage of CD38brightCD69+ cells
in HIV-infected infants was 5.4% higher than HIV-exposed
uninfected and 10.8% higher than HIV-unexposed infants (p =
0.005). Though there was a downward trend in the percent-
age of early activated NK cells in many infants over time, this
was statistically significant only in the HIV-unexposed infants in
the CD56dim subset (p = 0.005). Frequencies of CD38brightHLA-
DR+ cells were highly variable (Figure 4), and we did not find a
significant effect of HIV status or time in either the CD56bright,
CD56+CD16+ or CD56-CD16+ subsets (Figure 4C; p > 0.05
for each comparison of mean difference and slope).
APOPTOSIS-VULNERABILITY DURING ACUTE HIV INFECTION
A substantial frequency of apoptosis-vulnerable CD95+Bcl-2dim
cells was observed within the CD56bright subset, with a lower per-
centage in the CD56dim population (Figures 5A,B). We did not
detect a significant effect of HIV infection status on the per-
centage of vulnerable NK in either the CD56bright or CD56dim
subset (p > 0.05 for each, Figure 5C). Although percentages of
apoptosis-vulnerable cells increased in many infants, this did not
reach statistical significance in either the CD56bright or CD56dim
subset (p > 0.05 for each). In HIV-infected infants, the percent-
age of apoptosis-vulnerable cells in the CD56bright subset was
strongly correlated with the percentage of CD38brightHLA-DR+
cells (beta = 0.29, p = 0.02; Figure 5D), suggesting activation-
induced cell death (AICD) may account for the high level of
vulnerable cells in the CD56bright subset.
NK CELL DIFFERENTIATION DURING ACUTE HIV INFECTION
The transferrin receptor, CD71, regulates intracellular iron lev-
els and is undetectable on resting lymphocytes but upregulated
during their proliferation (Tormey et al., 1972; Dillner-Centerlind
et al., 1979; Trowbridge and Omary, 1981). NK cells expressed
substantial levels of the transferrin receptor, CD71, indicating
recent proliferation (Figure 6). NK cells expressed either CD71
or the differentiation marker CD57 exclusively (Figures 6A,B).
HIV-1 status did not have a significant effect on the percentage
of CD71+CD57– cells in either the CD56bright or CD56dim sub-
set (p > 0.05 for each). However, HIV status did have an effect
on the change in CD71+CD57- cells over time in the CD56bright
subset (p = 0.03 for comparison of slopes by HIV category);
we observed a trend for increasing frequencies of CD71+CD57-
cells in the HIV-infected infants (+0.70% per month, p = 0.06),
slowly decreasing frequencies of CD71+CD57- cells in HIV-
exposed uninfected (–0.49% per month, p = 0.08), and no
www.frontiersin.org December 2012 | Volume 3 | Article 399 | 5
Slyker et al. Infant NK cells and HIV-1
0
5
10
15
20
cord blood month 1 month 3 month 6 month 9 month 12
nktotal_axis
0
5
10
15
20
cord blood month 1 month 3 month 6 month 9 month 12
nktotal_axis
0
5
10
15
20
cord blood month 1 month 3 month 6 month 9 month 12
nktotal_axis
HIV-infected
%
 o
f l
ym
ph
oc
yt
es
%
 o
f l
ym
ph
oc
yt
es
%
 o
f l
ym
ph
oc
yt
es
HIV-exposed uninfected
HIV unexposed
0
20
40
60
80
100
cord blood month 1 month 3 month 6 month 9 month 12
0
20
40
60
80
100
cord blood month 1 month 3 month 6 month 9 month 12
0
20
40
60
80
100
cord blood month 1 month 3 month 6 month 9 month 12
%
 o
f N
K
 c
el
ls
%
 o
f N
K
 c
el
ls
%
 o
f N
K
 c
el
ls
Total NK
CD56bright
CD56+CD16+
LEGEND
CD56-CD16+
slope= -0.90% per month, p<0.001 CD56bright, slope= 0.23% per month, p=0.2
CD56+CD16+, slope= -1.3% per month,  p<0.001
CD56-CD16+, slope= 1.1% per month, p<0.001
slope= -0.11% per month, p=0.5 CD56
bright, slope= 0.065% per month, p=0.8
CD56+CD16+, slope= -0.57% per month,  p=0.03
CD56-CD16+, slope= 0.50% per month, p=0.04
slope= -0.40% per month, p=0.8 CD56bright, slope= -0.085% per month, p=0.8
CD56+CD16+, slope= -0.44% per month, p=0.5
CD56-CD16+, slope= 0.51% per month, p=0.006
(13) (12) (13) (11) (8) (8)
(5) (5) (5) (3) (4) (5)
(13) (12) (13) (11) (8) (8)
(5) (5) (5) (3) (4) (5)
(4) (3) (4) (3)
A
B
C
FIGURE 2 | Median frequencies of NK cell subsets in infants
grouped by HIV-1 infection/exposure during the first year of
life. Bars show median, with 25th and 75th percentiles for
HIV-infected infants (A), HIV-exposed uninfected infants (B), and
HIV-unexposed infants (C). (n) indicates number of infant specimens
tested at each time point. Linear mixed models were used to test for
the effect of age on percentage of cells; beta coefficients and p-values
for slope are provided.
change among HIV-unexposed (+0.073% per month, p = 0.9)
(Figure 6C).
In all infant groups, the percentage of differentiated CD71-
CD57+ cells in the CD56dim subset increased dramatically, con-
sistent with CD56dim NK cells serving as terminal effector cells
(Figure 6D). The HIV-unexposed infants had the most rapid
increase, gaining 5.6% per month (p < 0.001), followed by the
HIV-exposed uninfected (+2.9% per month, p < 0.001) and the
HIV-infected infants (+1.5% per month, p < 0.001). Although
HIV-1 status did not have a significant impact on the percentage
of CD71-CD57+ cells from the CD56dim subset (p = 0.2), HIV-1
status did impact the rate of accumulation of these cells (compar-
ison of slope by HIV status p = 0.004).
PERFORIN LEVELS DECLINE IN RESPONSE TO AGE AND HIV INFECTION
In cord blood lymphocytes, perforin was preferentially expressed
in CD56dim NK cells, with lower levels observed in CD8+ T lym-
phocytes, as expected (Figures 7A,B). In HIV-infected infants,
both the level of perforin (Figures 7C,D) and the percentage
(Figure 7E) of perforin-positive cells declined dramatically over
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Table 3 | Phenotypic composition of CD56bright and CD56dim subsets.
Phenotype % within CD56bright % within CD56dim Mean difference between CD56bright P-value
subset at baselinea subset at baselinea and CD56dim subsets
Early activated (CD38brightCD69+) 10% (6.5, 14) 14% (11, 18) –4.1 [–6.3, –1.9] <0.001
Activated (CD38brightHLA-DR+) 23% (15, 30) 14% (6.0, 21) +9.5 [4.9, 14] <0.001
Vulnerable (CD95+Bcl-2dim/−) 18% (12, 24) 7.3% (1.4, 13) +11 [7.0, 14] <0.001
Proliferating (CD71+CD57−) 46% (40, 53) 2.3% (–4.7, 8.7) +45 [41, 49] <0.001
Terminally differentiated (CD71−CD57+) 2.8% (–0.39, 6.1) 13% (9.9, 16) –10 [–14, –6.6] <0.001
Potentially cytolytic (perforin+) 33% (20, 46) 60% (47, 72) –28 [–36, –20] <0.001
Linear mixed models (LMM) were used to conduct within-subject paired comparisons for percent of activated, vulnerable, proliferating, differentiated, and potentially
cytotoxic cells gated on CD56bright vs. CD56dim cells.
aBaseline (birth) percentages are estimated by LMM model at time = 0 (y-intercept). Analysis uses all time-points from all infants (n = 26). The median number of
cells acquired was 446 cells (IQR = 207–980) for the CD56brightand 6647 cells (IQR = 2791–12,778) for the CD56dim subset.
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FIGURE 3 | CD38brightHLA-CD69+ NK cells. Representative flow cytometry
plots from NK cell subsets showing identification of CD38brightCD69+ cells
in (A) CD56bright and (B) CD56dim subsets at 1 and 6 months of age an
HIV-infected infant (B1-093). (C) Plots show individual infant trajectories as
connected lines of different colors, with overlaid linear mixed models
(LMM). LMM were used to determine whether slope (change in % of
cells/month) was affected by HIV infection status; where slopes are not
different, the slope representing the combined data of all infants is shown
to the box on the right. The mean difference across HIV groups is derived
from the beta coefficient for [HIV status] as described in the Materials
and Methods, and represents the % increase in cells per HIV category
from HIV-unexposed to HIV-exposed uninfected to HIV-infected. Slopes for
each HIV infection group are also presented separately within each
graph.
time in the CD56dim subset. HIV-infected infants lost approx-
imately 2.5% of perforin-positive cells per month (p < 0.001).
The HIV-exposed uninfected infants also experienced a decline
in the percentage of perforin-positive cells over time (−3.0%
per month, p = 0.01). In contrast, the HIV-unexposed infants
experienced an increase in perforin-positive cells over time
(Figures 7B,E; +5.1% per month, p = 0.02), consistent with
prior results indicating acquisition of perforin over time
(Luevano et al., 2012).
IMPACT OF HIV VIRAL LOAD ON NK SUBSETS AND PHENOTYPE
Finally, we examined the associations between viral load and
NK cell subset and phenotype in the HIV-infected infants. HIV-
1 RNA viral load was not significantly associated with either
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FIGURE 4 | CD38brightHLA-DR+ NK cells. Representative flow cytometry
plots from NK cell subsets showing identification of CD38brightHLA-DR+
cells at (A) 1 month and (B) 6 months of age an HIV-infected infant
(B1-093). (C) Plots show individual infant trajectories as connected lines
of different colors, with overlaid linear mixed models (LMM). LMM
were used to determine whether slope (change in % of cells/month)
was affected by HIV infection status; where slopes are not different,
the slope representing the combined data of all infants is shown to the
box on the right. The mean difference across HIV groups is derived
from the beta coefficient for [HIV status] as described in the Materials
and Methods, and represents the % increase in cells per HIV category
from HIV-unexposed to HIV-exposed uninfected to HIV-infected. Slopes
for each HIV infection group are also presented separately within
each graph.
the total NK cell percentage (p = 0.7), or the percentage of
CD56bright (p = 0.7), CD56+CD16+ (p = 0.5) or CD56-CD16+
(p = 0.4) cells.
For each 1-log10 increase in HIV-1 viral load, we observed
a 4.3% increase in the percentage of CD38brightHLA-DR+ cells
in the CD56bright subset (Table 4, p = 0.03). HIV-1 viral load
was negatively associated with the percentage of CD71+CD57−
cells in the CD56bright subset (beta coefficent = −4.5, p = 0.02).
There were no significant associations between the percentage of
early activated, apoptosis vulnerable, terminally differentiated, or
potentially cytotoxic NK cells and HIV-1 viral load in infected
infants.
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FIGURE 5 | CD95+Bcl-2dim NK cells. Representative flow cytometry
contour plots from NK cell subsets showing CD95 and Bcl-2 staining in
(A) CD56bright and (B) CD56dim subsets at 1 and 6 months of age an
HIV-infected infant (B1-093). (C) Plots show individual infant trajectories as
connected lines of different colors, with overlaid linear mixed models
(LMM). LMM were used to determine whether slope (change in % of
cells/month) was affected by HIV infection status; where slopes are not
different, the slope representing the combined data of all infants is shown
to the box on the right. The mean difference across HIV groups is derived
from the beta coefficient for [HIV status] as described in the Materials
and Methods, and represents the % increase in cells per HIV category
from HIV-unexposed to HIV-exposed uninfected to HIV-infected. Slopes for
each HIV infection group are also presented separately within each graph.
(D) LMM model shows correlation between percentages of CD38bright
HLA-DR+ cells and CD95+Bcl-2dim cells in the CD56bright subset, using
data from all infants.
DISCUSSION
Here we report that infant HIV infection is associated with alter-
ations in NK cell subsets, activation, and cytolytic potential that
could contribute to their poor control of HIV infection over
the first year of life. Additionally, the HIV-exposed uninfected
group exhibited a phenotype that was intermediate between
HIV-infected and HIV-unexposed infants in terms of activation
and perforin expression. This “intermediate” phenotype of HIV-
exposed uninfected infants could be indicative of the detrimental
effects of chronic exposure to HIV, or could reflect a pheno-
type more protective from HIV acquisition, in which relatively
blunted levels of activation, decreased proliferation, and more
rapidly maturing NK cells could contribute to resistance to HIV
acquisition.
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FIGURE 6 | CD71 and CD57 expression on NK cells. Representative flow
cytometry plots from NK cell subsets showing CD71 and CD57 staining in
(A) CD56bright and (B) CD56dim subsets at 1 and 6 months of age an
HIV-infected infant (B1-093). (C and D) Plots show individual infant
trajectories as connected lines of different colors, with overlaid linear
mixed models (LMM). LMM were used to determine whether slope
(change in % of cells/month) was affected by HIV infection status; where
slopes are not different, the slope representing the combined data of all
infants is shown to the box on the right. The mean difference across HIV
groups is derived from the beta coefficient for [HIV status] as described in
the Materials and Methods, and represents the % increase in cells per
HIV category from HIV-unexposed to HIV-exposed uninfected to
HIV-infected. Slopes for each HIV infection group are also presented
separately within each graph.
Several studies have indicated that NK cells play an impor-
tant role in the containment of HIV replication during primary
infection in adults (Fauci et al., 2005; Alter and Altfeld, 2009).
However, infant NK cells appear to be compromised in their
cytolytic capacity (Phillips et al., 1992; Bradstock et al., 1993;
Gaddy and Broxmeyer, 1997; Tanaka et al., 2003; Luevano et al.,
2012), and though they can suppress HIV replication in vitro by
secreting antiviral cytokines (Bernstein et al., 2004), it is not clear
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FIGURE 7 | Perforin content of NK cells. Representative flow cytometry
plots gated on lymphocytes show perforin content of CD8 and NK cells
over time in an (A) HIV-infected (B1-093) and (B) HIV-unexposed infant
(B1-119). Histograms show perforin levels at serial time-points in an
(C) HIV-infected and (D) HIV-unexposed infant, gated on the CD56dim
subset. (E) Plots show individual infant trajectories as connected lines of
different colors, with overlaid linear mixed models (LMM). LMM were
used to determine whether slope (change in % of cells/month) was
affected by HIV infection status. The mean difference across HIV groups
is derived from the beta coefficient for [HIV status] as described in the
Materials and Methods, and represents the % increase in cells per HIV
category from HIV-unexposed to HIV-exposed uninfected to HIV-infected.
Slopes for each HIV infection group are also presented separately within
each graph.
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Table 4 | Associations between HIV-1 RNA viral load and NK cell
phenotype.
Phenotype Subset Mean increase in % P-value
of cells per 1-log
increase in HIV-1 RNA
viral loada
Early activated CD56bright 0.80 0.6
(CD38brightCD69+) CD56dim 0.71 0.6
Activated CD56bright 4.3 0.03
(CD38brightHLA-DR+) CD56dim 0.14 0.9
Vulnerable CD56bright 1.2 0.7
(CD95+Bcl-2dim/−) CD56dim 1.6 0.3
Proliferating CD56bright −4.5 0.02
(CD71+CD57−) CD56dim −0.40 0.3
Terminally differentiated CD56bright 0.74 0.3
(CD71−CD57+) CD56dim +3.4 0.1
Potentially cytolytic CD56bright −6.6 0.1
(perforin+) CD56dim −6.0 0.1
aBeta coefficient for association between HIV-1 viral load and NK cell phenotype
from linear mixed-effects models with HIV-1 RNA viral load included in a model
with age.
whether these changes in NK cell function could contribute to
poor viral control. Although we were unable to directly assess NK
cell functions in this study, we hoped to gain insight the effects
of primary HIV infection and exposure on NK cell phenotype
in order to better understand the dynamic interplay between NK
cells and virus.
In adults, acute HIV infection is associated with a transient
expansion in CD56+CD16+NK cells that is followed by a decline
in total NK cell numbers and the development of an anergic
CD56-CD16+ NK cell population (Alter et al., 2005; Björkström
et al., 2010; Hong et al., 2010a). Since these alterations in NK
cell subset distribution and function are likely related to active
viral replication, the increased viral replication typical of infant
HIV infection could accelerate development of NK cell dysfunc-
tion and contribute to poor control over viral replication. As in
adults, we observed a decline in total NK cell percent in HIV-
infected infants over the first year of life (Azzoni et al., 2002;
Alter et al., 2005; Mantegani et al., 2010). However, the effect
of HIV-infection on NK subset distributions is less clear since
CD56-CD16+ NK cells were found in cord blood all infants at
birth (Bradstock et al., 1993; Gaddy et al., 1995). Thus, the pres-
ence of such cells could be a “normal” phenomenon, which may
be exacerbated by the effects of HIV infection. Consistent with
this hypothesis, we observed an increase in the proportion of
CD56-CD16+ NK cells over the first year of life in all infant
groups. It is possible that cytokine milieu required for matura-
tion of CD56-CD16+ neonatal NK cells may not fully develop
until after the first year of life, and that HIV infection further
compromises production of IL-2, IL-12, and/or IL-15 (Gaddy
and Broxmeyer, 1997; Yokoyama et al., 2004; Luevano et al.,
2012). In addition, in HIV-infected babies, active viral replication
could induce CD56dim cells to downregulate CD56 (Alter et al.,
2005; Björkström et al., 2010). The persistence and functions
of this atypical NK cell population in infants warrants further
evaluation.
Among the CD56+ subpopulations of NK cells, we observed
that CD56bright and CD56dim populations had relatively stable
characteristics that did not appear to be modified by HIV infec-
tion or exposure. While both populations expressed markers of
activation, CD56bright cells were more likely to proliferate and had
more cells vulnerable to apoptosis. In contrast, consistent with
their role as effectors, the CD56dim cells were more likely to be
terminally differentiated (CD71-CD57+) and express perforin.
These data highlight the dynamic status of the NK cell population
in the first year of life, in which the CD56bright cells may be actively
proliferating to fill the CD56dim effector cell pool. The CD56bright
cells appeared to bemore sensitive to perturbation caused byHIV,
consistent with results in adults (Mantegani et al., 2010). Since
activation was strongly correlated with vulnerability to apoptosis,
CD56bright cells may also be more susceptible to AICD.
Infant HIV infection was associated with an altered pheno-
type within specific NK subsets. There appeared to be a stepwise
effect of HIV infection and exposure on CD69 expression on NK
cells, with HIV-infected infants having the highest expression of
this marker on both CD56dim and CD56bright NK cells, followed
by HIV-exposed uninfected infants and then HIV-unexposed
infants. In fact, although we did not have sufficient power to
observe significant differences in many markers, HIV-exposed
uninfected babies also appeared to be intermediate in pheno-
type between HIV-infected and HIV-unexposed babies in terms
of perforin expression, activation status, and percentage of NK
cell subsets. These results are consistent with prior studies in
which lymphocytes from HIV-infected and exposed babies had
increased susceptibility to apoptosis in comparison to unexposed
babies (Economides et al., 1998). In addition, CD4+ T cells
from HIV-exposed uninfected infants became more activated yet
secreted less IL-2 than HIV-unexposed infants (Rich et al., 1997).
HIV exposure is associated with alterations in cytokine produc-
tion by cord blood mononuclear cells (Chougnet et al., 2000;
Kuhn et al., 2001), which could modulate NK cell activity in
HIV-infected and HIV-exposed uninfected babies.
Acute HIV infection and exposure was associated with dra-
matic alterations in the development of mature, functionally
competent NK cells, as has previously been observed in adults
(Hong et al., 2010b). In all infant groups, the percentage of CD57
cells increased rapidly during the first year of life; however, HIV
infection and exposure were associated with a slower increase in
fully differentiated, CD57+ NK cells, even though there were not
significant differences in the percentage of these cells between
groups. We suspect that the accumulation of CD57+ NK cells
may be counterbalanced by greater overall rates of AICD in
HIV-infected and HIV-exposed uninfected infants, though in
our small study we had limited power to evaluate this. We
also observed an increase in CD71 levels only in HIV-infected
infants; this could suggest that NK cell proliferation is increased
in this population, possibly as a response to persistent antigenic
stimulation.
The most dramatic effect of HIV exposure and infection on
infant NK cells was observed in the expression of perforin, a
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marker of cytolytic potential. As previously described, only a sub-
set of CD56dim NK cells in cord blood expressed perforin (Gaddy
et al., 1995; Gaddy and Broxmeyer, 1997). As expected, the
expression of perforin increased in CD56dim cells in healthy, HIV-
unexposed babies. However, HIV-infection, and less dramatically,
exposure in uninfected babies, was associated with a decrease
in expression of perforin over time. Similar results of low per-
forin expression during chronic HIV infection have been noted
in chronically HIV-infected adults (Alter et al., 2006; Qi et al.,
2006). This low perforin expression could reflect the fact that the
NK cells are actively degranulating in response to HIV infection
or that the aberrant inflammatory environment during HIV-1
infection is deficient in cytokines such as IL-15 that are required
for development of fully mature, perforin-expressing NK cells.
Both mechanisms could contribute to the dramatic decline in per-
forin expression in HIV-infected infants. However, HIV-exposed
uninfected infants also have low perforin levels that decline with
age. If this is a phenotype reflects a “protective phenotype,” this
could mean that non-cytolytic methods, such as cytokine secre-
tion, play a more important role in preventing HIV-1 acquisition
than cytolysis. However, the decline in perforin could also reflect
the detrimental effects of chronic exposure to HIV-1 and possi-
bly other pathogens from the HIV-infected mother. Regardless of
the mechanisms, the poor expression of perforin could compro-
mise cytolytic capacity of NK cells, and contribute to the poor
ability of HIV-infected and, to a lesser extent, HIV-exposed unin-
fected infants to control viral infection. Interestingly, Ballan et al.
found that HIV-infected children on ART had similar levels of
perforin as HIV-exposed uninfected children (Ballan et al., 2007).
As this study was of older children who received ART, it was not
clear whether provision of ART was associated with recovery of
perforin expression. Furthermore, this study did not include a
HIV-unexposed cohort, so it is not clear whether perforin levels
were low in both the HIV-infected/ART and HIV-exposed unin-
fected children relative to healthy, unexposed children. Together,
our data indicate that HIV exposure in utero and the maternal
environment can lead to relatively long-lasting effects on infant
immunity.
In HIV-infected infants, the level of viral replication was not
significantly associated with the total NK cell percentage or sub-
set distribution. This is somewhat distinct from the findings
in adults, in which higher levels of replication as associated
with increased frequencies of CD56-CD16+ NK cells (Alter and
Altfeld, 2009). However, the viral load was positively associated
with the percentage of activated CD38bright HLA-DR+ NK cells
and inversely associated with the percentage of CD71+CD57- NK
cells. These data suggest that high levels of HIV viral replication
during acute HIV infection may result in persistent activation and
cycling of NK cells, similar to what we have previously observed
in CD8 T cells (Slyker et al., 2011).
Our study has several strengths, and also some limitations.
To our knowledge, this study represents the first longitudinal
evaluation of HIV-infected and exposed infants during the first
year of life; with longitudinal follow-up, we were thus able
to avoid survival bias present in previous studies which eval-
uated HIV infection in older children (Azzoni et al., 2005;
Ballan et al., 2007). As myeloid lineage markers were not
used, it is possible that some of the CD56-CD16+ were small
myeloid lineage cells. Since this was a retrospective study, we
used frozen cells, which could potentially have skewed our
phenotypic data, due to preferential loss of some cell subsets
(particularly activated and apoptotic), and were unable to per-
form direct assessments of NK cell functions such as cytolytic
activity. Due to limitations in our staining panels, we were
unable to examine expression some markers previously shown
to be associated with functional alterations, such as expres-
sion of CD161 on NK T cells (Snyder-Cappione et al., 2009).
Our limited sample size, particularly for HIV-exposed unin-
fected and HIV-unexposed babies, decreased statistical power
to detect significant differences between groups, so we inter-
pret these results cautiously; indeed, with a larger sample size
additional effects of HIV-infection, or HIV-exposure are likely
to be found. Despite this limitation, we consistently observed
stepwise effects on NK cell phenotype, with the HIV-exposed
uninfected babies intermediate between HIV-infected and HIV-
unexposed babies. Other studies of HIV infection and expo-
sure have confirmed that HIV-exposed uninfected babies have
alterations in cytokine production that could modulate NK cell
activity (Rich et al., 1997; Chougnet et al., 2000; Kuhn et al.,
2001). Finally, NK cell distribution is likely altered by CMV
infection, which is highly prevalent in this population (Slyker
et al., 2009). However, although nearly all infants acquired CMV
infection by 3 months of age, we did not note changes in NK
cell phenotype concurrent with acute CMV infection (data not
shown).
In conclusion, in this well-characterized cohort we were able
to evaluate longitudinal effects of HIV exposure and infec-
tion on NK cells in infants. HIV infection was associated
with decreased total NK cell numbers, increased in differen-
tiation, and a significant decline in perforin expression over
time, which could functionally compromise infant NK cells.
We observed a similar, though muted pattern in the NK cells
of HIV-exposed uninfected infants. Together these data sug-
gest that HIV-induced alterations in the NK cells may con-
tribute to both poor viral control in HIV-infected infants and
altered susceptibility to infection in HIV-exposed uninfected
infants.
ACKNOWLEDGMENTS
We would like to express our thanks to the clinical, data, and lab-
oratory staff in Nairobi who made this study possible. Additional
thanks to Julie Overbaugh and Sandy Emery who conducted
HIV diagnostic assays for this study at the Fred Hutchison
Cancer Research Center, and Amir Horowitz for critical reading
of the manuscript. Most of all, we express our sincere grati-
tude to the women and infants in Nairobi who took part in
the study.
FUNDING
This work was funded by the National Institutes of Health (NIH)
through grants R01 HD-23412 (PI John-Stewart), K01AI087369-
01A1 (PI Slyker), K24 HD054314-06 (PI John-Stewart, K01
www.frontiersin.org December 2012 | Volume 3 | Article 399 | 13
Slyker et al. Infant NK cells and HIV-1
TW006080 (PI Lohman-Payne), the University of Washington
Center for AIDS Research (CFAR), an NIH funded program
(P30 AI 027757), an ARRA Administrative Supplement to the
University of Washington CFAR (PI Blish), and MRC grant
to the Human Immunology Unit of the Weatherall Institute
of Molecular Medicine (PI Rowland-Jones). Jennifer A. Slyker
and Barbara Lohman-Payne were also supported by Elizabeth
Glaser Pediatric AIDS Foundation grant MV-00-9-900-01872-0-
00 (PI Lohman-Payne). Jennifer A. Slyker was also supported by
the University of Washington STD and AIDS Research Training
Program, T32 AI007140 from the National Institutes of Health,
USPHS.
REFERENCES
Alter, G., and Altfeld, M. (2009). NK
cells in HIV-1 infection: evidence
for their role in the control of
HIV-1 infection. J. Intern. Med. 265,
29–42.
Alter, G., Malenfant, J. M., Delabre,
R. M., Burgett, N. C., Yu, X.
G., Lichterfeld, M., et al. (2004).
Increased natural killer cell activ-
ity in viremic HIV-1 infection.
J. Immunol. 173, 5305–5311.
Alter, G., Suscovich, T. J., Kleyman,
M., Teigen, N., Streeck, H., Zaman,
M. T., et al. (2006). Low per-
forin and elevated SHIP-1 expres-
sion is associated with functional
anergy of natural killer cells in
chronic HIV-1 infection. AIDS 20,
1549–1551.
Alter, G., Teigen, N., Ahern, R., Streeck,
H., Meier, A., Rosenberg, E. S.,
et al. (2007). Evolution of innate and
adaptive effector cell functions dur-
ing acute HIV−1 infection. J. Infect.
Dis. 195, 1452–1460.
Alter, G., Teigen, N., Davis, B. T., Addo,
M. M., Suscovich, T. J., Waring,
M. T., et al. (2005). Sequential
deregulation of NK cell subset dis-
tribution and function starting in
acute HIV-1 infection. Blood 106,
3366–3369.
Azzoni, L., Papasavvas, E., Chehimi,
J., Kostman, J. R., Mounzer,
K., Ondercin, J., et al. (2002).
Sustained impairment of IFN-
gamma secretion in suppressed
HIV-infected patients despite
mature NK cell recovery: evidence
for a defective reconstitution of
innate immunity. J. Immunol. 168,
5764–5770.
Azzoni, L., Rutstein, R. M., Chehimi, J.,
Farabaugh, M. A., Nowmos, A., and
Montaner, L. J. (2005). Dendritic
and natural killer cell subsets
associated with stable or declining
CD4+ cell counts in treated HIV-1-
infected children. J. Infect. Dis. 191,
1451–1459.
Ballan, W.M., Vu, B.-A. N., Long, B. R.,
Loo, C. P., Michaëlsson, J., Barbour,
J. D., et al. (2007). Natural killer
cells in perinatally HIV-1-infected
children exhibit less degranulation
compared to HIV-1-exposed unin-
fected children and their expres-
sion of KIR2DL3, NKG2C, and
NKp46 correlates with disease sever-
ity. J. Immunol. 179, 3362–3370.
Barker, E. E., Martinson, J. J., Brooks,
C. C., Landay, A. A., and Deeks,
S. S. (2007). Dysfunctional natu-
ral killer cells, in vivo, are gov-
erned by HIV viremia regardless of
whether the infected individual is
on antiretroviral therapy. AIDS 21,
2363–2365.
Bernstein, H., Kinter, A., Jackson, R.,
and Fauci, A. (2004). Neonatal
natural killer cells produce
chemokines and suppress HIV
replication in vitro. AIDS Res. Hum.
Retroviruses 20, 1189–1195.
Biron, C. A. (2010). Expansion,
maintenance, and memory in
NK and T cells during viral
infections: responding to pres-
sures for defense and regulation.
PLoS Pathog. 6:e1000816. doi:
10.1371/journal.ppat.1000816
Björkström, N. K., Ljunggren, H.-G.,
and Sandberg, J. K. (2010). CD56
negative NK cells: origin, function,
and role in chronic viral disease.
Trends Immunol. 31, 401–406.
Blanche, S. S., Tardieu, M. M., Duliege,
A. A., Rouzioux, C. C., Le Deist,
F. F., Fukunaga, K. K., et al.
(1990). Longitudinal study of 94
symptomatic infants with perina-
tally acquired human immunodefi-
ciency virus infection. Evidence for
a bimodal expression of clinical and
biological symptoms. Am. J. Dis.
Child. 144, 1210–1215.
Bollinger, R. C., Egan, M. A., Chun, T.
W., Mathieson, B., and Siliciano,
R. F. (1996). Cellular immune
responses to HIV-1 in progressive
and non-progressive infections.
AIDS 10 (Suppl. A), S85–S96.
Bradstock, K. F. K., Luxford, C. C.,
and Grimsley, P. G. P. (1993).
Functional and phenotypic assess-
ment of neonatal human leuco-
cytes expressing natural killer cell-
associated antigens. Immunol. Cell
Biol. 71(Pt 6), 535–542.
Brenner, B. G., Gryllis, C., Gornitsky,
M., and Wainberg, M. A. (1993).
Changes in natural immunity dur-
ing the course of HIV-1 infection.
Clin. Exp. Immunol. 93, 142–148.
Brunetta, E., Fogli, M., Varchetta,
S., Bozzo, L., Hudspeth, K. L.,
Marcenaro, E., et al. (2009). The
decreased expression of Siglec-7
represents an early marker of
dysfunctional natural killer-cell
subsets associated with high lev-
els of HIV-1 viremia. Blood 114,
3822–3830.
Cai, Q., Huang, X. L., Rappocciolo, G.,
and Rinaldo, C. R. (1990). Natural
killer cell responses in homosex-
ual men with early HIV infection.
J. Acquir. Immune Defic. Syndr. 3,
669–676.
Cerwenka, A., and Lanier, L. L. (2001).
Natural killer cells, viruses and
cancer. Nat. Rev. Immunol. 1,
41–49.
Chougnet, C. C., Kovacs, A. A.,
Baker, R. R., Mueller, B. U. B.,
Luban, N. L. N., Liewehr, D. J. D.,
et al. (2000). Influence of human
immunodeficiency virus-infected
maternal environment on devel-
opment of infant interleukin-12
production. J. Infect. Dis. 181,
1590–1597.
De Maria, A., Fogli, M., Costa, P.,
Murdaca, G., Puppo, F., Mavilio,
D., et al. (2003). The impaired
NK cell cytolytic function in
viremic HIV-1 infection is asso-
ciated with a reduced surface
expression of natural cytotoxicity
receptors (NKp46, NKp30 and
NKp44). Eur. J. Immunol. 33,
2410–2418.
De Rossi, A. A., Masiero, S. S.,
Giaquinto, C. C., Ruga, E. E.,
Comar, M. M., Giacca, M. M.,
et al. (1996). Dynamics of viral
replication in infants with vertically
acquired human immunodeficiency
virus type 1 infection. J. Clin. Invest.
97, 323–330.
Dickover, R. E. R., Dillon, M. M.,
Leung, K. M. K., Krogstad, P. P.,
Plaeger, S. S., Kwok, S. S., et al.
(1998). Early prognostic indica-
tors in primary perinatal human
immunodeficiency virus type 1
infection: importance of viral RNA
and the timing of transmission on
long-term outcome. J. Infect. Dis.
178, 375–387.
Dillner-Centerlind, M. L., Hammar-
ström, S., and Perlmann, P. (1979).
Transferrin can replace serum
for in vitro growth of mitogen-
stimulated T lymphocytes. Eur. J.
Immunol. 9, 942–948.
Economides, A., Schmid, I., Anisman-
Posner, D. J., Plaeger, S., Bryson,
Y. J., and Uittenbogaart, C. H.
(1998). Apoptosis in cord blood
T lymphocytes from infants of
human immunodeficiency virus-
infected mothers. Clin. Diagn. Lab.
Immunol. 5, 230–234.
Eller, M. A., Eller, L. A., Ouma,
B. J., Thelian, D., Gonzalez, V.
D., Guwatudde, D., et al. (2009).
Elevated natural killer cell activity
despite altered functional and phe-
notypic profile in Ugandans with
HIV-1 clade A or clade D infection.
J. Acquir. Immune Defic. Syndr. 51,
380–389.
Emery, S., Bodrug, S., Richardson,
B. A., Giachetti, C., Bott, M.
A., Panteleeff, D., et al. (2000).
Evaluation of performance of the
Gen-Probe human immunodefi-
ciency virus type 1 viral load assay
using primary subtype A, C, and
D isolates from Kenya. J. Clin.
Microbiol. 38, 2688–2695.
Fauci, A. S., Mavilio, D., and Kottilil, S.
(2005). NK cells in HIV infection:
paradigm for protection or targets
for ambush. Nat. Rev. Immunol. 5,
835–843.
Fogli, M., Costa, P., Murdaca, G., Setti,
M., Mingari, M. C., Moretta, L.,
et al. (2004). Significant NK cell
activation associated with decreased
cytolytic function in peripheral
blood of HIV-1-infected patients.
Eur. J. Immunol. 34, 2313–2321.
Gaddy, J., and Broxmeyer, H. E. (1997).
Cord blood CD16+56- cells with
low lytic activity are possible pre-
cursors of mature natural killer cells.
Cell. Immunol. 180, 132–142.
Gaddy, J., Risdon, G., and Broxmeyer,
H. E. (1995). Cord blood natu-
ral killer cells are functionally and
phenotypically immature but read-
ily respond to interleukin-2 and
interleukin-12. J. Interferon Cytokine
Res. 15, 527–536.
Gandhi, R. T., and Walker, B. D.
(2002). Immunologic control
of HIV-1. Annu. Rev. Med. 53,
149–172.
Goulder, P. J. R., Jeena, P., Tudor-
Williams, G., and Burchett, S.
(2001). Paediatric HIV infection:
correlates of protective immu-
nity and global perspectives in
Frontiers in Immunology | NK Cell Biology December 2012 | Volume 3 | Article 399 | 14
Slyker et al. Infant NK cells and HIV-1
prevention and management. Br.
Med. Bull. 58, 89–108.
Hansasuta, P. P., and Rowland-Jones,
S. L. S. (2001). HIV-1 transmission
and acute HIV-1 infection. Br. Med.
Bull. 58, 109–127.
Hess, C., Altfeld, M., Thomas, S. Y.,
Addo, M. M., Rosenberg, E. S.,
Allen, T. M., et al. (2004). HIV-1
specific CD8+ T cells with an effec-
tor phenotype and control of viral
replication. Lancet 363, 863–866.
Hong, H. S., Eberhard, J. M., Keudel,
P., Bollmann, B. A., Ahmad, F.,
Ballmaier, M., et al. (2010a).
Phenotypically and functionally
distinct subsets contribute to the
expansion of CD56-/CD16+ natural
killer cells in HIV infection. AIDS
24, 1823–1834.
Hong, H. S., Eberhard, J. M., Keudel,
P., Bollmann, B. A., Ballmaier, M.,
Bhatnagar, N., et al. (2010b). HIV
infection is associated with a pref-
erential decline in less-differentiated
CD56dim CD16+ NK cells. J. Virol.
84, 1183–1188.
Hu, P. F., Hultin, L. E., Hultin, P.,
Hausner, M. A., Hirji, K., Jewett,
A., et al. (1995). Natural killer cell
immunodeficiency in HIV disease
is manifest by profoundly decreased
numbers of CD16+CD56+ cells
and expansion of a population of
CD16dimCD56- cells with low lytic
activity. J. Acquir. Immune Defic.
Syndr. 10, 331–340.
John-Stewart, G. C., Mbori-Ngacha,
D., Payne, B. L., Farquhar, C.,
Richardson, B. A., Emery, S., et al.
(2009). HIV-1–specific cytotoxic T
lymphocytes and breast milk HIV-
1 transmission. J. Infect. Dis. 199,
889–898.
Koup, R. A., Safrit, J. T., Cao, Y.,
Andrews, C. A., McLeod, G.,
Borkowsky, W., et al. (1994).
Temporal association of cellular
immune responses with the initial
control of viremia in primary
human immunodeficiency virus
type 1 syndrome. J. Virol. 68,
4650–4655.
Kuhn, L., Coutsoudis, A., Moodley, D.,
Mngqundaniso, N., Trabattoni,
D., Shearer, G. M., et al.
(2001). Interferon-gamma and
interleukin-10 production among
HIV-1-infected and uninfected
infants of HIV-1-infected mothers.
Pediatr. Res. 50, 412–416.
Lanier, L. L. (2008). Evolutionary
struggles between NK cells and
viruses. Nat. Rev. Immunol. 8,
259–268.
Lifson, J. D., Nowak, M. A., Goldstein,
S., Rossio, J. L., Kinter, A., Vasquez,
G., et al. (1997). The extent
of early viral replication is a
critical determinant of the natural
history of simian immunodefi-
ciency virus infection. J. Virol. 71,
9508–9514.
Lohman, B. L., Slyker, J. A., Richardson,
B. A., Farquhar, C., Mabuka, J.
M., Crudder, C., et al. (2005).
Longitudinal assessment of human
immunodeficiency virus type 1
(HIV-1)-specific gamma interferon
responses during the first year of life
in HIV-1-infected infants. J. Virol.
79, 8121–8130.
Luevano, M., Daryouzeh, M.,
Alnabhan, R., Querol, S., Khakoo,
S., Madrigal, A., et al. (2012). The
unique profile of cord blood natural
killer cells balances incomplete
maturation and effective killing
function upon activation. Hum.
Immunol. 73, 248–257.
Luzuriaga, K., Wu, H., McManus,
M., Britto, P., Borkowsky, W.,
Burchett, S., et al. (1999). Dynamics
of human immunodeficiency
virus type 1 replication in verti-
cally infected infants. J. Virol. 73,
362–367.
Mantegani, P., Tambussi, G., Galli, L.,
Din, C. T., Lazzarin, A., and Fortis,
C. (2010). Perturbation of the nat-
ural killer cell compartment during
primary human immunodeficiency
virus 1 infection primarily involving
the CD56brightsubset. Immunology
129, 220–233.
Mavilio, D., Benjamin, J., Daucher,
M., Lombardo, G., Kottilil, S.,
Planta, M. A., et al. (2003). Natural
killer cells in HIV-1 infection:
dichotomous effects of viremia on
inhibitory and activating receptors
and their functional correlates.
Proc. Natl. Acad. Sci. U.S.A. 100,
15011–15016.
Mavilio, D., Lombardo, G., Kinter, A.,
Fogli, M., La Sala, A., Ortolano, S.,
et al. (2006). Characterization of
the defective interaction between
a subset of natural killer cells
and dendritic cells in HIV-
1 infection. J. Exp. Med. 203,
2339–2350.
Mellors, J. W., Rinaldo, C. R., Gupta,
P., White, R. M., Todd, J. A., and
Kingsley, L. A. (1996). Prognosis in
HIV-1 infection predicted by the
quantity of virus in plasma. Science
272, 1167–1170.
Obimbo, E. M., Mbori-Ngacha, D. A.,
Ochieng, J. O., Richardson, B. A.,
Otieno, P. A., Bosire, R., et al.
(2004). Predictors of early mortality
in a cohort of human immunodefi-
ciency virus type 1-infected african
children. Pediatr. Infect. Dis. J. 23,
536–543.
Panteleeff, D. D. D., John, G. G.,
Nduati, R. R., Mbori-Ngacha, D. D.,
Richardson, B. B., Kreiss, J. J., et al.
(1999). Rapid method for screening
dried blood samples on filter paper
for human immunodeficiency virus
type 1 DNA. J. Clin. Microbiol. 37,
350–353.
Penazzato, M., Prendergast, A., Tierney,
J., Cotton, M., and Gibb, D. (2012).
Effectiveness of antiretroviral ther-
apy in HIV-infected children under
2 years of age. Cochrane Database
Syst. Rev. 7:CD004772. doi:
10.1002/14651858.CD004772.pub3
Phillips, J. H., Hori, T., Nagler, A.,
Bhat, N., Spits, H., and Lanier,
L. L. (1992). Ontogeny of human
natural killer (NK) cells: fetal NK
cells mediate cytolytic function and
express cytoplasmic CD3 epsilon,
delta proteins. J. Exp. Med. 175,
1055–1066.
Qi, W., Yongjun, J., Yanan, W., Zining,
Z., Xiaoxu, H., Jing, L., et al.
(2006). Differential expression of
perforin in cytotoxic lymphocyte in
HIV/AIDS patients of china. J. Clin.
Immunol. 26, 339–346.
Rich, K. C., Siegel, J. N., Jennings,
C., Rydman, R. J., and Landay, A.
L. (1997). Function and phenotype
of immature CD4+ lymphocytes in
healthy infants and early lympho-
cyte activation in uninfected infants
of human immunodeficiency virus-
infected mothers. Clin. Diagn. Lab.
Immunol. 4, 358–361.
Richardson, B. A., Mbori-Ngacha, D.,
Lavreys, L., John-Stewart, G. C.,
Nduati, R., Panteleeff, D. D., et al.
(2003). Comparison of human
immunodeficiency virus type 1
viral loads in kenyan women,
men, and infants during primary
and early infection. J. Virol. 77,
7120–7123.
Shaffer, N. N., Roongpisuthipong,
A. A., Siriwasin, W. W.,
Chotpitayasunondh, T. T.,
Chearskul, S. S., Young, N. L.
N., et al. (1999). Maternal virus
load and perinatal human immun-
odeficiency virus type 1 subtype E
transmission, Thailand. Bangkok
collaborative perinatal HIV trans-
mission study group. J. Infect. Dis.
179, 590–599.
Slyker, J. A., John-Stewart, G. C.,
Dong, T., Lohman-Payne, B., Reilly,
M., Atzberger, A., et al. (2011).
Phenotypic characterization of
HIV-specific CD8+ T cells during
early and chronic infant HIV-1
infection. PLoS ONE 6:e20375. doi:
10.1371/journal.pone.0020375
Slyker, J. A., Lohman-Payne,
B. L., John-Stewart, G. C.,
Maleche-Obimbo, E., Emery,
S., Richardson, B., et al. (2009).
Acute cytomegalovirus infection in
Kenyan HIV-infected infants. AIDS
23, 2173–2181.
Slyker, J. A., Rowland-Jones, S. L.,
Dong, T., Reilly, M., Richardson, B.,
Emery, V. C., et al. (2012). Acute
cytomegalovirus infection is associ-
ated with increased frequencies of
activated and apoptotic-vulnerable
T cells in HIV-1 infected infants.
J. Virol. 86, 11373–11379.
Snyder-Cappione, J. E., Loo, C. P.,
Carvalho, K. I., Kuylenstierna,
C., Deeks, S. G., Hecht, F. M.,
et al. (2009). Lower cytokine
secretion ex vivo by natural killer
T cells in HIV-infected individ-
uals is associated with higher
CD161 expression. AIDS 23,
1965–1970.
Tanaka, H. H., Kai, S. S., Yamaguchi,
M. M., Misawa, M. M., Fujimori,
Y. Y., Yamamoto, M. M., et al.
(2003). Analysis of natural killer
(NK) cell activity and adhesion
molecules on NK cells from umbili-
cal cord blood. Eur. J. Haematol. 71,
29–38.
Tomescu, C., Abdulhaqq, S., and
Montaner, L. J. (2011). Evidence
for the innate immune response as
a correlate of protection in human
immunodeficiency virus (HIV)-1
highly exposed seronegative sub-
jects (HESN). Clin. Exp. Immunol.
164, 158–169.
Tormey, D. C., Imrie, R. C.,
and Mueller, G. C. (1972).
Identification of transferrin as
a lymphocyte growth promoter in
human serum. Exp. Cell Res. 74,
163–169.
Trowbridge, I. S., and Omary, M. B.
(1981). Human cell surface gly-
coprotein related to cell prolifera-
tion is the receptor for transfer-
rin. Proc. Natl. Acad. Sci. U.S.A. 78,
3039–3043.
Ullum,H., Cozzi Lepri, A., Aladdin, H.,
Katzenstein, T., Victor, J., Phillips, A.
N., et al. (1999). Natural immunity
and HIV disease progression. AIDS
13, 557–563.
Ullum, H. H., Gøtzsche, P. C. P.,
Victor, J. J., Dickmeiss, E. E.,
Skinhøj, P. P., and Pedersen, B.
K. B. (1995). Defective natural
immunity: an early manifesta-
tion of human immunodeficiency
virus infection. J. Exp. Med. 182,
789–799.
Verneris, M. R., and Miller, J. S.
(2009). The phenotypic and func-
tional characteristics of umbilical
cord blood and peripheral blood
natural killer cells. Br. J. Haematol.
147, 185–191.
Vivier, E., Raulet, D. H., Moretta,
A., Caligiuri, M. A., Zitvogel, L.,
Lanier, L. L., et al. (2011). Innate
www.frontiersin.org December 2012 | Volume 3 | Article 399 | 15
Slyker et al. Infant NK cells and HIV-1
or adaptive immunity? The example
of natural killer cells. Science 331,
44–49.
Walker, C. M. C., Thomson-Honnebier,
G. A. G., Hsueh, F. C. F., Erickson,
A. L. A., Pan, L. Z. L., and Levy,
J. A. J. (1991). CD8+ T cells from
HIV-1-infected individuals inhibit
acute infection by human and
primate immunodeficiency viruses.
Cell. Immunol. 137, 420–428.
Yokoyama, W. M., Kim, S., and French,
A. R. (2004). The dynamic life
of natural killer cells. Annu. Rev.
Immunol. 22, 405–429.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 28 September 2012; accepted:
10 December 2012; published online: 31
December 2012.
Citation: Slyker JA, Lohman-Payne
B, John-Stewart GC, Dong T,
Mbori-Ngacha D, Tapia K, Atzberger
A, Taylor S, Rowland-Jones SL and
Blish CA (2012) The impact of HIV-1
infection and exposure on natural killer
(NK) cell phenotype in Kenyan infants
during the first year of life. Front.
Immun. 3:399. doi: 10.3389/fimmu.
2012.00399
This article was submitted to Frontiers in
NK Cell Biology, a specialty of Frontiers
in Immunology.
Copyright © 2012 Slyker, Lohman-
Payne, John-Stewart, Dong,
Mbori-Ngacha, Tapia, Atzberger,
Taylor, Rowland-Jones and Blish.
This is an open-access article dis-
tributed under the terms of the Creative
Commons Attribution License, which
permits use, distribution and repro-
duction in other forums, provided
the original authors and source are
credited and subject to any copyright
notices concerning any third-party
graphics etc.
Frontiers in Immunology | NK Cell Biology December 2012 | Volume 3 | Article 399 | 16
